Education
About Us
Working with TipRanks
Follow Us
Medistim ASA (DE:MD1)
FRANKFURT:MD1
MD1 Stock Chart & Stats
€20.90
€0.30(2.46%)
At close: 4:00 PM EST
€20.90
€0.30(2.46%)
Day’s Range― - ―
52-Week Range€11.10 - €24.40
Previous CloseN/A
Volume0.00
Average Volume (3M)1.00
Market Cap
€416.60M
Enterprise Value€3.75B
Total Cash (Recent Filing)€183.45M
Total Debt (Recent Filing)€26.17M
Price to Earnings (P/E)34.6
Beta0.45
Next Earnings
Mar 04, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding18,337,336
10 Day Avg. Volume1
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medistim ASA News
MD1 FAQ
What was Medistim ASA’s price range in the past 12 months?
Medistim ASA lowest stock price was €11.10 and its highest was €24.40 in the past 12 months.
What is Medistim ASA’s market cap?
Medistim ASA’s market cap is €416.60M.
When is Medistim ASA’s upcoming earnings report date?
Medistim ASA’s upcoming earnings report date is Mar 04, 2026 which is in 115 days.
How were Medistim ASA’s earnings last quarter?
Medistim ASA released its earnings results on Oct 24, 2025. The company reported €0.082 earnings per share for the quarter, missing the consensus estimate of €0.138 by -€0.056.
Is Medistim ASA overvalued?
According to Wall Street analysts Medistim ASA’s price is currently Overvalued.
Does Medistim ASA pay dividends?
Medistim ASA does not currently pay dividends.
What is Medistim ASA’s EPS estimate?
Medistim ASA’s EPS estimate is 0.13.
How many shares outstanding does Medistim ASA have?
Medistim ASA has 18,337,336 shares outstanding.
What happened to Medistim ASA’s price movement after its last earnings report?
Medistim ASA reported an EPS of €0.082 in its last earnings report, missing expectations of €0.138. Following the earnings report the stock price went up 2.336%.
Which hedge fund is a major shareholder of Medistim ASA?
Currently, no hedge funds are holding shares in DE:MD1
Company Description
Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Technical Analysis
Options Prices
Currently, No data available
---